SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New approach targets hidden driver of lupus heart risks
Disease control Not yet recruitingThis study is testing whether a supplement called 2-HOBA can help lower blood pressure and calm overactive immune cells in people with lupus. 42 participants with stable lupus will take either 2-HOBA or a placebo for 4 weeks each, with a break in between. Researchers will measure…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First-in-Human trial launches for 'Living Drug' aiming to tame severe lupus
Disease control Not yet recruitingThis is an early-stage safety study testing a new type of cell therapy called KN5501 for adults with moderate to severe, hard-to-treat systemic lupus erythematosus (SLE). Researchers will give patients an infusion of specially engineered immune cells designed to target and reduce…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: Ruitherapeutics Co., LTD • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC